BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15567636)

  • 1. Most severe neutropenia in individuals with no chronic condition did not result in a specific diagnosis.
    Petitti DB; Contreras R; Glowalla M; Miday R
    J Clin Epidemiol; 2004 Nov; 57(11):1182-7. PubMed ID: 15567636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical significance of non-malignant neutropenia in hospitalized children.
    Vlacha V; Feketea G
    Ann Hematol; 2007 Dec; 86(12):865-70. PubMed ID: 17653547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Descriptive epidemiology of agranulocytosis.
    Strom BL; Carson JL; Schinnar R; Snyder ES; Shaw M
    Arch Intern Med; 1992 Jul; 152(7):1475-80. PubMed ID: 1627027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The vulnerabilities of age: burns in children and older adults.
    Bessey PQ; Arons RR; Dimaggio CJ; Yurt RW
    Surgery; 2006 Oct; 140(4):705-15; discussion 715-7. PubMed ID: 17011919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate and severe neutropenia in patients with systemic lupus erythematosus.
    Martínez-Baños D; Crispín JC; Lazo-Langner A; Sánchez-Guerrero J
    Rheumatology (Oxford); 2006 Aug; 45(8):994-8. PubMed ID: 16484291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of vancomycin-induced neutropenia in patients receiving home intravenous infusion therapy.
    Pai MP; Mercier RC; Koster SA
    Ann Pharmacother; 2006 Feb; 40(2):224-8. PubMed ID: 16434560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the incidence of leukopenia and neutropenia with valproate, quetiapine, or the combination in children and adolescents.
    Rahman A; Mican LM; Fischer C; Campbell AH
    Ann Pharmacother; 2009 May; 43(5):822-30. PubMed ID: 19401471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy.
    Caggiano V; Weiss RV; Rickert TS; Linde-Zwirble WT
    Cancer; 2005 May; 103(9):1916-24. PubMed ID: 15751024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged acquired neutropenia in children.
    Sheen JM; Kuo HC; Yu HR; Huang EY; Wu CC; Yang KD
    Pediatr Blood Cancer; 2009 Dec; 53(7):1284-8. PubMed ID: 19711442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and prevalence of inflammatory bowel disease in a Northern California managed care organization, 1996-2002.
    Herrinton LJ; Liu L; Lewis JD; Griffin PM; Allison J
    Am J Gastroenterol; 2008 Aug; 103(8):1998-2006. PubMed ID: 18796097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiosyncratic drug-induced agranulocytosis or acute neutropenia.
    Andrès E; Maloisel F
    Curr Opin Hematol; 2008 Jan; 15(1):15-21. PubMed ID: 18043241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional differences in outcomes for hospitalized injured patients.
    Mullins RJ; Diggs BS; Hedges JR; Newgard CD; Arthur M; Adams AL; Veum-Stone J; Lenfesty B; Trunkey DD
    J Trauma; 2006 Apr; 60(4):691-8; discussion 699-700. PubMed ID: 16612288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of aplastic anemia: a prospective multicenter study.
    Montané E; Ibáñez L; Vidal X; Ballarín E; Puig R; García N; Laporte JR;
    Haematologica; 2008 Apr; 93(4):518-23. PubMed ID: 18322256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based study of invasive disease due to beta-hemolytic streptococci of groups other than A and B.
    Broyles LN; Van Beneden C; Beall B; Facklam R; Shewmaker PL; Malpiedi P; Daily P; Reingold A; Farley MM
    Clin Infect Dis; 2009 Mar; 48(6):706-12. PubMed ID: 19187026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization.
    Weng X; Liu L; Barcellos LF; Allison JE; Herrinton LJ
    Am J Gastroenterol; 2007 Jul; 102(7):1429-35. PubMed ID: 17437504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe pediatric influenza in California, 2003-2005: implications for immunization recommendations.
    Louie JK; Schechter R; Honarmand S; Guevara HF; Shoemaker TR; Madrigal NY; Woodfill CJ; Backer HD; Glaser CA
    Pediatrics; 2006 Apr; 117(4):e610-8. PubMed ID: 16585278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based assessment of hospitalizations for neutropenia from chemotherapy in older adults with non-Hodgkin's lymphoma (United States).
    Chen-Hardee S; Chrischilles EA; Voelker MD; Brooks JM; Scott S; Link BK; Delgado D
    Cancer Causes Control; 2006 Jun; 17(5):647-54. PubMed ID: 16633911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A semimechanistic-physiologic population pharmacokinetic/pharmacodynamic model for neutropenia following pemetrexed therapy.
    Latz JE; Karlsson MO; Rusthoven JJ; Ghosh A; Johnson RD
    Cancer Chemother Pharmacol; 2006 Apr; 57(4):412-26. PubMed ID: 16322990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trauma center utilization for children in California 1998-2004: trends and areas for further analysis.
    Wang NE; Chan J; Mahlow P; Wise PH
    Acad Emerg Med; 2007 Apr; 14(4):309-15. PubMed ID: 17296799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of hospital-treated Salmonella infection; data from a national cohort over a ten-year period.
    Gil Prieto R; Alejandre CG; Meca AA; Barrera VH; de Miguel AG
    J Infect; 2009 Mar; 58(3):175-81. PubMed ID: 19195712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.